The Superfund program at University of California Davis has produced assays for many environmentally hazardous materials. The application of these bioassays in fast, multi-analyte instruments requires further work that will be undertaken in the Biosensor projects. Initially, engineering of surface microdot systems will be carried out for model assays for atrazine and metabolites. Small dots of antibodies will be printed onto a surface and then exposed to samples. The sensitivity of the surface microdot system will be explored on the model assay. Automation of steps in cell based assays will also be investigated. Novel fluorescence labels will be developed in collaboration with other projects in the program. Three classes of new labels will be tested; they include porphyrins and lanthanides that are amenable to time resolved fluorescence detection. Fluorescence resonance energy transfer (FRET) will be investigated as a promising label. Experiments will be carried out on simple solutions and on a model assay for atrazine to evaluate sensitivity and detection limits. Microdroplets will be investigated a novel format for fluorescence detection. Micron sized droplets of sample with be interrogated with a laser. The possibility of using non linear optical processes, such as droplet lasing, in the microdroplets will be determined. Microfabrication technology will be used to design and fabricate miniaturized systems for immunoassays. Sample handling and processing will be incorporated into the miniaturized device. Ultrasonic agitation will be investigated as a way to improve binding rates. Finally, the miniaturized immunoassay system will be interfaced with novel detection methods, using new fluorophores and new detection formats (such as microdroplets). The sensitivity, detection limits, and turn around time of the packaged system, will be evaluated on atrazine and other compounds of interest, including dioxin and human reproductive hormones.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-16
Application #
6580385
Study Section
Special Emphasis Panel (ZES1)
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
16
Fiscal Year
2002
Total Cost
$165,230
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Philippat, Claire; Barkoski, Jacqueline; Tancredi, Daniel J et al. (2018) Prenatal exposure to organophosphate pesticides and risk of autism spectrum disorders and other non-typical development at 3 years in a high-risk cohort. Int J Hyg Environ Health 221:548-555
Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry et al. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 28:2302-2313
Wang, Weicang; Yang, Jun; Zhang, Jianan et al. (2018) Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A 115:5283-5288
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695

Showing the most recent 10 out of 1149 publications